Back
Monopar Therapeutics Stock Price Chart
He's already IPO'd once - this time's different
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
51
MNPR
Monopar Therapeutics
Last Price:
$37.00
Seasonality Move:
-0.36%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.41 | Buy |
| 20-day SMA: | 36.04 | Buy |
| 50-day SMA: | 37.32 | Buy |
| 200-day SMA: | 18.94 | Buy |
| 8-day EMA: | 34.05 | Buy |
| 20-day EMA: | 34.56 | Buy |
| 50-day EMA: | 34.44 | Buy |
| 200-day EMA: | 23.13 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 54.18 | Buy |
| Chaikin Money Flow: | 15636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.62 - 39.34) | Buy |
| Bollinger Bands (100): | (23.12 - 40.52) | Buy |
Monopar Therapeutics Technical Analysis
| Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 37.49 while MNPR 8-day simple moving average is 32.41, which is a Buy signal.
-
The stock price of MNPR is 37.49 while Monopar Therapeutics 20-day SMA is 36.04, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 37.32 while MNPR share price is 37.49, making it a Buy technically.
-
MNPR stock price is 37.49 and Monopar Therapeutics 200-day simple moving average is 18.94, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $37.49. The Score for MNPR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
229.2M
Price in USD:
37.49
Share Volume:
20K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 37.49 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 37.49 while MNPR 8-day exponential moving average is 34.05, which is a Buy signal.
-
The stock price of MNPR is 37.49 while Monopar Therapeutics 20-day EMA is 34.56, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 34.44 while MNPR share price is 37.49, making it a Buy technically.
-
MNPR stock price is 37.49 and Monopar Therapeutics 200-day simple moving average is 23.13, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.58, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 54.18, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (30.62 - 39.34), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (23.12 - 40.52), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.